Apatinib mesylate tablets in the treatment of recurrent glioblastoma, open II single arm clinical study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update:
12 Jan 2018
Price :
$35
*
-
Adis is an information provider.
-
Final gross price and currency may vary according to local VAT and billing address.
-
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
-
A link to download a PDF version of the trial profile will be included in your email receipt.